ED
OKS

Exane Derivatives’s Oneok Partners LP OKS Stock Holding History

Exane Derivatives’s Portfolio OKS Stock Details OKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-23
Closed -$1.17K – 675
2017
Q2 		$1.17K Sell
23
-1
-4% -$51 ﹤0.01% 467
2017
Q1 		$1.3K Sell
24
-8
-25% -$400 ﹤0.01% 403
2016
Q4 		$1.38K Buy
32
+1
+3% +$41 ﹤0.01% 464
2016
Q3 		$1.24K Sell
31
-5
-14% -$200 ﹤0.01% 475
2016
Q2 		$1.44K Sell
36
-15
-29% -$549 ﹤0.01% 412
2016
Q1 		$1.6K Hold
51
– – ﹤0.01% 463
2015
Q4 		$1.54K Hold
51
– – ﹤0.01% 388
2015
Q3 		$1.49K Buy
51
+7
+16% +$226 ﹤0.01% 410
2015
Q2 		$1.5K Hold
44
– – ﹤0.01% 429
2015
Q1 		$1.8K Sell
44
-349
-89% -$14.6K ﹤0.01% 426
2014
Q4 		$15.6K Buy
+393
New +$18.6K ﹤0.01% 398

Other funds holding OKS

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
ACM
Adalta Capital Management New York $228M AUM 26.26% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Exane Derivatives's OKS Position: Q3 2017 in Review

Exane Derivatives sold out of Oneok Partners LP (OKS) in Q3 2017, closing a stake of 23 shares — an estimated $1.17K sold.

Exane Derivatives first reported a position in OKS in Q4 2014 and held it in 11 quarters. The position peaked at $15.6K in Q4 2014. 5 funds tracked by Wall St. Rank hold OKS as of Q3 2017.

  • Exane Derivatives reported no remaining Oneok Partners LP position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 23 Oneok Partners LP shares in Q3 2017, an estimated $1.17K.
  • Exane Derivatives first reported a position in Oneok Partners LP in Q4 2014 and held it in 11 quarters.
  • Exane Derivatives's Oneok Partners LP position peaked at $15.6K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Oneok Partners LP as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.